Weight-loss drugs are expensive, but Connecticut has a plan

The high cost of new weight-loss drugs is causing some insurers to cut coverage, but a new program in Connecticut may offer a more sustainable way to provide coverage while still limiting costs, Kelly Hooper writes for Politico.

4 things leaders need to know about high-cost drugs

New weight-loss drugs may be too costly to cover

New GLP-1 weight-loss drugs, such as Novo Nordisk’s Wegovy, have surged in popularity in recent months. But their high costs — which can reach over $1,000 a month — have made getting coverage for the drugs difficult.

Currently, Medicare does not cover weight-loss medications,...